| The new measuring multimorbidity index predicted mortality better than Charlson and Elixhauser indices among the general population J Stanley, D Sarfati Journal of clinical epidemiology 92, 99-110, 2017 | 846 | 2017 |
| The impact of comorbidity on cancer and its treatment D Sarfati, B Koczwara, C Jackson CA: a cancer journal for clinicians 66 (4), 337-350, 2016 | 703 | 2016 |
| Global cancer incidence in older adults, 2012 and 2035: a population‐based study S Pilleron, D Sarfati, M Janssen‐Heijnen, J Vignat, J Ferlay, F Bray, ... International journal of cancer 144 (1), 49-58, 2019 | 566 | 2019 |
| Measuring cancer survival in populations: relative survival vs cancer-specific survival D Sarfati, T Blakely, N Pearce International journal of epidemiology 39 (2), 598-610, 2010 | 255 | 2010 |
| Estimated global cancer incidence in the oldest adults in 2018 and projections to 2050 S Pilleron, E Soto‐Perez‐de‐Celis, J Vignat, J Ferlay, I Soerjomataram, ... International journal of cancer 148 (3), 601-608, 2021 | 227 | 2021 |
| SF-36 health survey reliability, validity and norms for New Zealand KM Scott, MI Tobias, D Sarfati, SJ Haslett Australian and New Zealand journal of public health 23 (4), 401-406, 1999 | 220 | 1999 |
| Survival disparities in Indigenous and non-Indigenous New Zealanders with colon cancer: the role of patient comorbidity, treatment and health service factors S Hill, D Sarfati, T Blakely, B Robson, G Purdie, J Chen, E Dennett, ... Journal of Epidemiology & Community Health 64 (2), 117-123, 2010 | 205 | 2010 |
| Comorbidity prevalence among cancer patients: a population-based cohort study of four cancers H Fowler, A Belot, L Ellis, C Maringe, MA Luque-Fernandez, EN Njagi, ... BMC cancer 20, 1-15, 2020 | 198 | 2020 |
| Review of methods used to measure comorbidity in cancer populations: no gold standard exists D Sarfati Journal of clinical epidemiology 65 (9), 924-933, 2012 | 170 | 2012 |
| The effect of comorbidity on the use of adjuvant chemotherapy and survival from colon cancer: a retrospective cohort study D Sarfati, S Hill, T Blakely, B Robson, G Purdie, E Dennett, D Cormack, ... BMC cancer 9, 1-10, 2009 | 164 | 2009 |
| Risk factors for cryptorchidism JK Gurney, KA McGlynn, J Stanley, T Merriman, V Signal, C Shaw, ... Nature Reviews Urology 14 (9), 534-548, 2017 | 161 | 2017 |
| Cannabis exposure and risk of testicular cancer: a systematic review and meta-analysis J Gurney, C Shaw, J Stanley, V Signal, D Sarfati BMC cancer 15, 1-10, 2015 | 151 | 2015 |
| International trends in the incidence of testicular cancer: lessons from 35 years and 41 countries JK Gurney, AA Florio, A Znaor, J Ferlay, M Laversanne, D Sarfati, F Bray, ... European urology 76 (5), 615-623, 2019 | 149 | 2019 |
| The impact of patient comorbidity on cancer stage at diagnosis J Gurney, D Sarfati, J Stanley British journal of cancer 113 (9), 1375-1380, 2015 | 126 | 2015 |
| A challenge to the cross-cultural validity of the SF-36 health survey: Factor structure in Māori, Pacific and New Zealand European ethnic groups KM Scott, D Sarfati, MI Tobias, SJ Haslett Social Science & Medicine 51 (11), 1655-1664, 2000 | 124 | 2000 |
| Consideration of comorbidity in treatment decision making in multidisciplinary cancer team meetings: a systematic review J Stairmand, L Signal, D Sarfati, C Jackson, L Batten, M Holdaway, ... Annals of Oncology 26 (7), 1325-1332, 2015 | 123 | 2015 |
| Risk of lower limb amputation in a national prevalent cohort of patients with diabetes JK Gurney, J Stanley, S York, D Rosenbaum, D Sarfati Diabetologia 61, 626-635, 2018 | 121 | 2018 |
| Does the frame affect the picture? A study into how attitudes to screening for cancer are affected by the way benefits are expressed D Sarfati, P Howden-Chapman, A Woodward, C Salmond Journal of Medical Screening 5 (3), 137-140, 1998 | 117 | 1998 |
| Indigenous inequalities in cancer: what role for health care? S Hill, D Sarfati, B Robson, T Blakely ANZ journal of surgery 83 (1-2), 36-41, 2013 | 114 | 2013 |
| Changing global policy to deliver safe, equitable, and affordable care for women’s cancers O Ginsburg, R Badwe, P Boyle, G Derricks, A Dare, T Evans, A Eniu, ... The Lancet 389 (10071), 871-880, 2017 | 107 | 2017 |
